Shanxi C&Y Pharmaceutical Group Co Ltd (300254) - Total Assets

Latest as of March 2026: CN¥1.59 Billion CNY ≈ $232.44 Million USD

Based on the latest financial reports, Shanxi C&Y Pharmaceutical Group Co Ltd (300254) holds total assets worth CN¥1.59 Billion CNY (≈ $232.44 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore 300254 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Shanxi C&Y Pharmaceutical Group Co Ltd - Total Assets Trend (2008–2025)

This chart illustrates how Shanxi C&Y Pharmaceutical Group Co Ltd's total assets have evolved over time, based on quarterly financial data. See 300254 total equity for net asset value and shareholders' equity analysis.

Shanxi C&Y Pharmaceutical Group Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Shanxi C&Y Pharmaceutical Group Co Ltd's total assets of CN¥1.59 Billion consist of 36.8% current assets and 63.2% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	9.8%
Accounts Receivable	CN¥207.28 Million	12.6%
Inventory	CN¥132.91 Million	8.1%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥204.46 Million	12.5%
Goodwill	CN¥311.99 Million	19.0%

Asset Composition Trend (2008–2025)

This chart illustrates how Shanxi C&Y Pharmaceutical Group Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Shanxi C&Y Pharmaceutical Group Co Ltd.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Shanxi C&Y Pharmaceutical Group Co Ltd's current assets represent 36.8% of total assets in 2025, a decrease from 55.0% in 2008.
Cash Position: Cash and equivalents constituted 9.8% of total assets in 2025, up from 2.8% in 2008.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 30.0% of total assets, an increase from 11.0% in 2008.
Asset Diversification: The largest asset category is goodwill at 19.0% of total assets.

Shanxi C&Y Pharmaceutical Group Co Ltd Competitors by Total Assets

Key competitors of Shanxi C&Y Pharmaceutical Group Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	China	CN¥19.57 Billion
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	China	CN¥2.30 Billion
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	China	CN¥8.59 Billion
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	China	CN¥925.41 Million
Jw Pharmac KO:001060	Korea	₩605.27 Billion
Kamada TA:KMDA	Israel	ILA377.21 Million
Samjin Pharm KO:005500	Korea	₩449.14 Billion

Shanxi C&Y Pharmaceutical Group Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	0.98	0.96	1.17
Quick Ratio	0.72	0.65	0.85
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥-8.77 Million	CN¥-18.84 Million	CN¥71.44 Million

Shanxi C&Y Pharmaceutical Group Co Ltd - Advanced Valuation Insights

This section examines the relationship between Shanxi C&Y Pharmaceutical Group Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	4.71
Latest Market Cap to Assets Ratio	0.18
Asset Growth Rate (YoY)	6.1%
Total Assets	CN¥1.64 Billion
Market Capitalization	$302.75 Million USD

Valuation Analysis

Below Book Valuation: The market values Shanxi C&Y Pharmaceutical Group Co Ltd's assets below their book value (0.18x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Shanxi C&Y Pharmaceutical Group Co Ltd's assets grew by 6.1% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Shanxi C&Y Pharmaceutical Group Co Ltd (2008–2025)

The table below shows the annual total assets of Shanxi C&Y Pharmaceutical Group Co Ltd from 2008 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥1.64 Billion ≈ $240.36 Million	+6.13%
2024-12-31	CN¥1.55 Billion ≈ $226.48 Million	+8.00%
2023-12-31	CN¥1.43 Billion ≈ $209.70 Million	-9.55%
2022-12-31	CN¥1.58 Billion ≈ $231.84 Million	+3.77%
2021-12-31	CN¥1.53 Billion ≈ $223.42 Million	-15.20%
2020-12-31	CN¥1.80 Billion ≈ $263.47 Million	-0.08%
2019-12-31	CN¥1.80 Billion ≈ $263.69 Million	+20.48%
2018-12-31	CN¥1.50 Billion ≈ $218.87 Million	-1.51%
2017-12-31	CN¥1.52 Billion ≈ $222.22 Million	+6.00%
2016-12-31	CN¥1.43 Billion ≈ $209.63 Million	+9.49%
2015-12-31	CN¥1.31 Billion ≈ $191.46 Million	+10.76%
2014-12-31	CN¥1.18 Billion ≈ $172.87 Million	+8.34%
2013-12-31	CN¥1.09 Billion ≈ $159.56 Million	+31.82%
2012-12-31	CN¥827.16 Million ≈ $121.04 Million	+17.73%
2011-12-31	CN¥702.56 Million ≈ $102.81 Million	+150.17%
2010-12-31	CN¥280.84 Million ≈ $41.10 Million	+8.22%
2009-12-31	CN¥259.51 Million ≈ $37.97 Million	+15.77%
2008-12-31	CN¥224.15 Million ≈ $32.80 Million	--

About Shanxi C&Y Pharmaceutical Group Co Ltd

SHE:300254 China Drug Manufacturers - Specialty & Generic

Market Cap

$302.75 Million

CN¥2.07 Billion CNY

Market Cap Rank

#14717 Global

#4350 in China

Share Price

CN¥8.08

Change (1 day)

+3.19%

52-Week Range

CN¥7.27 - CN¥14.68

All Time High

CN¥31.09